GSD type IV (Andersen disease)

Pathophysiology - Faulty Glycogen Branches

• Enzyme Defect: Deficiency of the glycogen branching enzyme (amylo-α-1,4→α-1,6-transglucosidase).
• Genetic Basis: Autosomal recessive mutation in the GBE1 gene.
• Abnormal Glycogen Structure:
  • Fewer branches and long outer chains, creating an amylopectin-like structure.
  • This abnormal glycogen has ↓ decreased solubility, causing it to precipitate in tissues.
• Cellular Injury:
  • Insoluble glycogen deposits (polyglucosan bodies) act as foreign bodies.
  • Triggers a host immune response, leading to fibrosis, and ultimately organ failure (e.g., progressive liver cirrhosis).

⭐ The abnormal glycogen deposits are PAS-positive and diastase-resistant.

Clinical Presentation - Liver's Rocky Road

• Early Infancy Onset: Typically presents within the first 18 months of life with classic signs of liver dysfunction.
• Failure to Thrive: Poor weight gain and growth retardation are prominent early indicators.
• Progressive Hepatosplenomegaly: The liver and spleen progressively enlarge. The liver feels unusually firm, evolving to a nodular texture characteristic of cirrhosis.
• Variable Muscle & Heart Involvement: Some patients may also exhibit hypotonia, muscle weakness, and cardiomyopathy, complicating the clinical picture.

⭐ The core pathology is aggressive hepatic fibrosis. The abnormal, insoluble glycogen precipitates, provoking an immune response that rapidly destroys the liver, leading to death by age 5 without a transplant.

Diagnosis - Confirming the Culprit

• Enzyme Assay: Definitive test measuring glycogen branching enzyme (GBE) activity in liver, muscle, or skin fibroblasts.
• Liver Biopsy: Histology is key.
  • Shows PAS-positive, diastase-resistant inclusions (abnormal glycogen).
  • Reveals progressive fibrosis leading to cirrhosis.
• Genetic Testing: Confirms diagnosis by identifying mutations in the GBE1 gene.
• Prenatal Diagnosis: Possible via amniocentesis or chorionic villus sampling (CVS).

⭐ Exam Favorite: The pathognomonic finding on liver biopsy is the presence of cytoplasmic inclusions that are PAS-positive but resistant to diastase digestion, unlike normal glycogen which is digested.

Management - Support & Transplant

• Mainstay: Primarily supportive care, focusing on nutritional management to prevent hypoglycemia and manage progressive liver dysfunction.
• Curative: Liver transplantation is the only definitive treatment for hepatic failure, often required in early childhood.

⭐ Transplant corrects the hepatic disease, but extrahepatic manifestations like cardiomyopathy may persist and progress.

• Deficiency: Branching enzyme (α-1,4 → α-1,6 glucosyltransferase).
• Inheritance: Autosomal recessive.
• Pathology: Accumulation of abnormal, unbranched glycogen (amylopectin-like) in hepatocytes.
• Clinical Hallmark: Presents in infancy with failure to thrive, hepatosplenomegaly, and rapidly progressive liver cirrhosis.
• Mechanism: The abnormal glycogen structure provokes a foreign-body immune reaction, leading to hepatic fibrosis.
• Prognosis: Typically results in death from liver failure by age 5.